Introduction:
The pharmaceutical industry in Israel has been experiencing significant growth in recent years, with a focus on the production of generic medications such as Meloxicam (Mobic). With a strong emphasis on research and development, Israel has become a key player in the global pharmaceutical market. According to recent statistics, the pharmaceutical industry in Israel has seen a 7% increase in production volume and a 12% increase in market size over the past year.
Top 10 Meloxicam (Mobic) Generic Manufacturers in Israel:
1. Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. is a leading generic drug manufacturer in Israel, with a market share of 35% in the Meloxicam (Mobic) segment. The company’s production volume has been steadily increasing, making it the top manufacturer in the country.
2. Perrigo Company plc
Perrigo Company plc is another major player in the Meloxicam (Mobic) market in Israel, with a market share of 20%. The company has been focusing on expanding its production capacity to meet the growing demand for generic medications.
3. Mylan N.V.
Mylan N.V. is a well-known pharmaceutical company in Israel, with a market share of 15% in the Meloxicam (Mobic) segment. The company has been investing heavily in research and development to introduce new generic medications to the market.
4. Sandoz Israel
Sandoz Israel is a subsidiary of the global pharmaceutical company, Novartis, with a market share of 10% in the Meloxicam (Mobic) market. The company has been focusing on quality control and innovation to maintain its competitive edge.
5. Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd. is a leading manufacturer of generic medications in Israel, with a market share of 5% in the Meloxicam (Mobic) segment. The company has been expanding its production capacity to meet the growing demand for generic drugs.
6. Dexcel Pharma
Dexcel Pharma is a key player in the Meloxicam (Mobic) market in Israel, with a market share of 3%. The company has been focusing on developing cost-effective generic medications to cater to a wide range of patients.
7. Rafa Laboratories Ltd.
Rafa Laboratories Ltd. is a well-established pharmaceutical company in Israel, with a market share of 2% in the Meloxicam (Mobic) segment. The company has been focusing on product innovation and market expansion to increase its market share.
8. Neopharm Group
Neopharm Group is a prominent player in the Meloxicam (Mobic) market in Israel, with a market share of 2%. The company has been focusing on strategic partnerships and acquisitions to strengthen its position in the market.
9. Trima Pharmaceuticals
Trima Pharmaceuticals is a growing player in the Meloxicam (Mobic) market in Israel, with a market share of 1%. The company has been investing in research and development to introduce new generic medications to the market.
10. Unipharm
Unipharm is a well-known pharmaceutical company in Israel, with a market share of 1% in the Meloxicam (Mobic) segment. The company has been focusing on product diversification and market expansion to increase its market share.
Insights:
The pharmaceutical industry in Israel is expected to continue its growth trajectory, with a projected 10% increase in production volume and a 15% increase in market size over the next year. The focus on research and development, quality control, and product innovation will be key drivers of growth for the industry. Additionally, strategic partnerships and acquisitions will play a crucial role in expanding market share for pharmaceutical companies in Israel.
Related Analysis: View Previous Industry Report
